ScreenerHero

CNTNCanton Strategic Holdings Inc. Common Stock

NAS · US · Healthcare · Biotechnology · cantonstrategic.com
2.190USD+4.78%Mkt Cap: 174.50M $P/E: —

Canton Strategic Holdings, Inc. engages in the institutional blockchain adoption and digitization of financial markets in the United States. It operates in two segments, Digital Asset Treasury and Clinical Stage Bio-tech…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap174.50M $
Enterprise Value138.85M $
Revenue (TTM)1.50M $
Gross Profit1.50M $
Net Income (TTM)-35.92M $
Revenue/Share0.0190 USD
Last Price2.190 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees12
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue92.83
P/S117.72
P/B0.38
EPS (TTM)-0.16
EPS (Forward)—
52W Range
1.08114% of range9.080
52W High9.080 USD
52W Low1.081 USD
Profitability
Gross Margin100.00%
Oper. Margin-80.36%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-9.03%
ROA-6.92%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-16.13M $
CapEx (TTM)77.57M $
FCF Margin-85.15%
FCF Yield-0.73%
Net Debt-37.24M $
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio15.70
Quick Ratio14.18
Book Value/Sh5.887 USD
Cash/Share0.4670 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateMay 28, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.79.68M
Float72.71M
Insiders16.95%
Institutions24.92%
Short Interest
Short Ratio11.2d
Short % Float11.16%
Short % Out.11.02%
Shares Short8.50M
Short (prev mo.)6.98M
Technical
SMA 502.399 (-8.7%)
SMA 2003.136 (-30.2%)
Beta1.47
S&P 52W Chg18.16%
Avg Vol (30d)705.73K
Avg Vol (10d)575.93K
Technical Indicators
RSI (14)54.2
MACD-0.0843
MACD Signal-0.1445
MACD Hist.+0.0602
BB Upper2.145 USD
BB Middle1.968 USD
BB Lower1.790 USD
BB Width18.05%
ATR (14)0.1544 USD
Vol Ratio (20d)1.05x